Showing results (551-560 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|February 18, 2003
Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathwayMichelle Alonso, Cristina Tamasdan, Douglas C Miller, et al.
Molecular Cancer Therapeutics|February 18, 2003
p53-independent response to cisplatin and oxaliplatin in MMTV-ras mouse salivary tumorsThierry Petit, David J Bearss, Dean A Troyer, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Molecular Cancer Therapeutics|January 19, 2008
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)Lincoln A Edwards, Janet Woo, Lynsey A Huxham, et al.
Molecular Cancer Therapeutics|January 19, 2008
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effectsMoritz Palmowski, Jochen Huppert, Gesa Ladewig, et al.
Molecular Cancer Therapeutics|January 19, 2008
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growthBrian Clem, Sucheta Telang, Amy Clem, et al.
Molecular Cancer Therapeutics|January 19, 2008
2-[(1-methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidationKelly Huber, Poulam Patel, Lei Zhang, et al.
Molecular Cancer Therapeutics|January 19, 2008
z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivoDong Xiao, Shivendra V Singh
Molecular Cancer Therapeutics|January 19, 2008
Identification of a novel blocker of IkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaBBokyung Sung, Manoj K Pandey, Yuki Nakajima, et al.
Molecular Cancer Therapeutics|March 6, 2008
Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodiesFeng An, Daryl C Drummond, Shannon Wilson, et al.
Pageof 599